Citation: Mg. Sanda, COMPARISON OF RADICAL PROSTATECTOMY AND IODINE-125 INTERSTITIAL RADIOTHERAPY FOR THE TREATMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER - A 7-YEAR BIOCHEMICAL (PSA) PROGRESSION ANALYSIS - COMMENT, Urology, 51(6), 1998, pp. 890-890
Authors:
HSU CX
ROSS BD
CHRISP CE
DERROW SZ
CHARLES LG
PIENTA KJ
GREENBERG NM
ZENG Z
SANDA MG
Citation: Cx. Hsu et al., LONGITUDINAL COHORT ANALYSIS OF LETHAL PROSTATE-CANCER PROGRESSION INTRANSGENIC MICE, The Journal of urology, 160(4), 1998, pp. 1500-1505
Authors:
SANDA MG
WEI JT
KING K
OESTERLING JE
MONTIE JE
Citation: Mg. Sanda et al., PROSPECTIVE LONGITUDINAL ANALYSIS OF PATIENT REPORTED OUTCOMES AFTER RADICAL PROSTATECTOMY, The Journal of urology, 159(5), 1998, pp. 231-231
Authors:
HAYMAN JA
WANG SB
MCLAUGHLIN PW
SULLIVAN MA
SANDA MG
MONTIE JE
REDDY SC
WATSON GA
JOHNSON NF
SANDLER HM
Citation: Ja. Hayman et al., 3-DIMENSIONAL CONFORMAL RADIATION-THERAPY FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE-CANCER, The Journal of urology, 159(5), 1998, pp. 238-238
Authors:
SANDA MG
DOEHRING CB
BINKOWITZ B
BEATY TH
PARTIN AW
HALE E
STONER E
WALSH PC
Citation: Mg. Sanda et al., CLINICAL AND BIOLOGICAL CHARACTERISTICS OF FAMILIAL BENIGN PROSTATIC HYPERPLASIA, The Journal of urology, 157(3), 1997, pp. 876-879
Citation: Mg. Sanda et al., EVOLUTION OF OUTCOMES WITH THE ILEAL HYDRAULIC VALVE CONTINENT DIVERSION - REEVALUATION OF THE BENCHEKROUN CATHETERIZABLE STOMA, World journal of urology, 14(2), 1996, pp. 108-111
Authors:
SANDA MG
RESTIFO NP
WALSH JC
KAWAKAMI Y
NELSON WG
PARDOLL DM
SIMONS JW
Citation: Mg. Sanda et al., MOLECULAR CHARACTERIZATION OF DEFECTIVE ANTIGEN-PROCESSING IN HUMAN PROSTATE-CANCER, Journal of the National Cancer Institute, 87(4), 1995, pp. 280-285
Citation: Rg. Moore et al., RETROPERITONEOSCOPY - EFFECTS OF INSUFFLATION MEDIA ON SURROUNDING TISSUE DURING BALLOON RUPTURE, Journal of endourology, 9(1), 1995, pp. 67-71
Authors:
PARTIN AW
PIANTADOSI S
SANDA MG
EPSTEIN JI
MARSHALL FF
MOHLER JL
BRENDLER CB
WALSH PC
SIMONS JW
Citation: Aw. Partin et al., SELECTION OF MEN AT HIGH-RISK FOR DISEASE RECURRENCE FOR EXPERIMENTALADJUVANT THERAPY FOLLOWING RADICAL PROSTATECTOMY, Urology, 45(5), 1995, pp. 831-838
Authors:
CARDUCCI MA
AYYAGARI SR
SANDA MG
SIMONS JW
Citation: Ma. Carducci et al., GENE-THERAPY FOR HUMAN PROSTATE-CANCER - TRANSLATIONAL RESEARCH IN THE HORMONE-REFRACTORY DUNNING PROSTATE-CANCER MODEL, Cancer, 75(7), 1995, pp. 2013-2020
Authors:
COLE DJ
SANDA MG
YANG JC
SCHWARTZENTRUBER DJ
WEBER J
ETTINGHAUSEN SE
POCKAJ BA
KIM HI
LEVIN RD
POGREBNIAK HW
BALKISSOON J
FENTON RM
DEBARGE LR
KAYE J
ROSENBERG SA
PARKINSON DR
Citation: Dj. Cole et al., PHASE-I TRIAL OF RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR ADMINISTERED BY CONTINUOUS INTRAVENOUS-INFUSION IN PATIENTS WITH METASTATIC CANCER, Journal of the National Cancer Institute, 86(1), 1994, pp. 39-45
Authors:
SANDA MG
AYYAGARI SR
JAFFEE EM
EPSTEIN JI
CLIFT SL
COHEN LK
DRANOFF G
PARDOLL DM
MULLIGAN RC
SIMONS JW
Citation: Mg. Sanda et al., DEMONSTRATION OF A RATIONAL STRATEGY FOR HUMAN PROSTATE-CANCER GENE-THERAPY, The Journal of urology, 151(3), 1994, pp. 622-628